Full-time Senior QC Laboratory Analyst Singapore 30+ days agoView job Full-time E&I Specialist Tuas 30+ days agoView job Full-time Lead Process Technician (Day) Singapore Apply with your Indeed Resume 30+ days agoView job slide5 of 6 Full-time Process Engineer Tuas 30+ days agoView job ...
Careers Search Jobs Career Growth & Development Connect With Us Partners Research and Business Development Partnerships Venture Investments Business to Business Pfizer CentreOne Pfizer Ignite Submit Your Opportunities Overview > Investor Relations > Overview Events & Presentations View More All Events Latest...
Singapore -English Slovenia -Slovenian Slovakia -Slovenský South Africa -English Spain -Español Sweden -Svenska Switzerland -Deutsch -Français Taiwan -繁體中文 Thailand -ภาษาไทย Turkey -Türk Uruguay -Español United Kingdom -English ...
Pfizer Quarterly Corporate Performance - First Quarter 2025 Add to Calendar Event Announcement(opens in new window) Webcast(opens in new window) 03.28.2025 Pfizer Pflash: A Spotlight on IRA Part D Redesign and its Impact in 2025 Presentation(opens in new window) ...
02.04.2025 Pfizer Quarterly Corporate Performance - Fourth Quarter 2024 Press Release(opens in new window) Presentation(opens in new window) Prepared Remarks(opens in new window) Infographic(opens in new window) Transcript(opens in new window) ...
Singapore Slovakia Slovenia South Africa Spain Sudan Suriname (Caribbean Region) Swaziland Sweden Switzerland Syria Taiwan Thailand Trinidad & Tobago (Caribbean Region) Tunisia Turkey Ukraine United Arab Emirates United Kingdom United States Uruguay US Virgin Islands Venezuel...
The Integrative Computational Sciences (ICS) group at Lilly Singapore Centre for Drug Discovery (LSCDD), provides state-of-the-art computational solutions to enable the global efforts of drug discovery, translational medicine and tailored therapeutics at the post genomic era. We study the genetics ...
Celine Y Tan et al. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study. Lancet Infectious Disease (2023).https://doi.org/10.1016/S1473-3099(23)00060-9 ...
In addition to receiving regulatory approval in the U.S., CIBINQO has received marketing authorization in the European Union, Great Britain, Japan, Korea, the United Arab Emirates, Norway, Iceland, and Singapore. About Atopic Dermatitis AD is a chronic skin disease characterized by...
NEWSROOM INVESTORS CAREERS Search...Search...Takeda Pharmaceuticals: Global Homepage From lost art to a lasting connectionLearn More Recent News Takeda Announces Completion of Acquisition of Own Shares April 22, 2025 Takeda to Hold Earnings Call for Fiscal Year 2024 on May 8 April 17, 2025 ...